Sarcopenia is a geriatric condition featured by a progressive loss of muscle mass and
function and associated with various adverse health outcomes. In this review, we aimed to …

Background Sarcopenia is defined as the loss of muscle mass and strength. Despite the
seriousness of this disease, a single diagnostic criterion has not yet been established. Few …

Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …

Background Chronic inflammation has been associated with sarcopenia and its components
skeletal muscle strength and muscle mass. The aim of this systematic review and meta …

Clinical and research interest in sarcopenia has burgeoned internationally, Asia included.
The Asian Working Group for Sarcopenia (AWGS) 2014 consensus defined sarcopenia as …

Background: Sarcopenia can predispose individuals to falls, fractures, hospitalization, and
mortality. The prevalence of sarcopenia depends on the population studied and the …

The term sarcopenia was first introduced in 1988 by Irwin Rosenberg to define a condition of
muscle loss that occurs in the elderly. Since then, a broader definition comprising not only …

Type 2 diabetes mellitus (T2DM) represents a major health burden for the elderly
population, affecting approximately 25% of people over the age of 65 years. This percentage …

The definition of sarcopenia, the age-related loss of muscle mass, has evolved since the
term's inception and yet there is no consensus. Many of the identified definitions of …

The term sarcopenia was introduced in 1988. The original definition was a “muscle loss” of
the appendicular muscle mass in the older people as measured by dual energy x‐ray …